Mannatech,
Incorporated
(NASDAQ: MTEX),
a leading developer and provider of nutritional supplements and skin
care products based on Real
Food Technology® solutions, today reported for
the quarter ended March 31, 2011 net sales of $50.9 million, and a net
loss of $4.8 million, or $0.18 per diluted share. Quarterly sales
declined $9.8 million or 16.1%, compared to the first quarter of 2010.
The net loss increased by $2.0 million for the quarter largely due to
the effect of the sales decline in the United States along with the
costs associated with the launch of operations in Mexico.
Mannatech successfully commenced operations in Mexico in late January of
2011, bringing the number of total operating countries to 17. Randy
Bancino, president of international operations, said, "We are pleased
with the initial launch of Mannatech Mexico, and have been extremely
impressed with the dedication and energy shown by our new independent
Associates there. The warm welcome and support extended to us by our
Mexican Associate Leaders has been gratifying, and we look forward to
working closely with them to build a substantial and lasting business
opportunity.”
New independent Associates and Members totaled 19,057 in the first
quarter of 2011, compared to 20,913 in the first quarter of 2010, an
decrease of 9.0%. Total independent Associate and Member count based on
a 12-month trailing period was approximately 392,000 as of March 31,
2011 as compared to 485,000 as of March 31, 2010.
Conference Call
Mannatech will hold a conference call and webcast to discuss this
announcement with investors on Thursday, May 5, 2011 at 9:00 a.m.
Central Daylight Time, 10:00 a.m. Eastern Daylight Time. Investors may
listen to the call by accessing Mannatech’s website at http://ir.mannatech.com/phoenix.zhtml?c=62253&p=irol-irhome.
Individuals interested in Mannatech’s products or in exploring its
business opportunity can learn more at mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. These proprietary
products are available through independent sales Associates around the
globe including the United States, Canada, South Africa, Australia, New
Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the
United Kingdom, Japan, Taiwan, Singapore, the Republic of Korea and
Mexico. For more information, visit mannatech.com.
Please Note: This release contains "forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as "intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties, and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain independent
associates and members, increases in competition, litigation, regulatory
changes, and its planned growth into new international markets. Although
Mannatech believes that the expectations, statements, and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its latest
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.
|
|
|
|
|
Net Sales in Dollars and as a Percentage of Consolidated Net
Sales – (Unaudited)
|
|
|
|
|
|
|
|
Three months ended March 31,
|
|
Country
|
|
2011
|
|
|
2010
|
|
|
|
|
(in millions, except percentages)
|
|
United States
|
|
$
|
22.4
|
|
44.0
|
%
|
|
$
|
27.8
|
|
45.8
|
%
|
|
Japan
|
|
|
7.5
|
|
14.7
|
%
|
|
|
8.7
|
|
14.3
|
%
|
|
Republic of Korea
|
|
|
5.2
|
|
10.2
|
%
|
|
|
5.4
|
|
8.9
|
%
|
|
Australia
|
|
|
4.5
|
|
8.8
|
%
|
|
|
5.2
|
|
8.6
|
%
|
|
Canada
|
|
|
4.0
|
|
7.9
|
%
|
|
|
4.4
|
|
7.2
|
%
|
|
South Africa
|
|
|
2.1
|
|
4.1
|
%
|
|
|
3.2
|
|
5.3
|
%
|
|
Taiwan
|
|
|
1.2
|
|
2.3
|
%
|
|
|
2.2
|
|
3.6
|
%
|
|
Mexico(1)
|
|
|
0.7
|
|
1.4
|
%
|
|
|
—
|
|
—
|
|
|
New Zealand
|
|
|
0.6
|
|
1.2
|
%
|
|
|
1.0
|
|
1.6
|
%
|
|
Singapore
|
|
|
0.6
|
|
1.2
|
%
|
|
|
0.6
|
|
1.0
|
%
|
|
Germany
|
|
|
0.5
|
|
1.0
|
%
|
|
|
0.6
|
|
1.0
|
%
|
|
Norway
|
|
|
0.5
|
|
1.0
|
%
|
|
|
0.3
|
|
0.5
|
%
|
|
The Netherlands
|
|
|
0.3
|
|
0.6
|
%
|
|
|
0.1
|
|
0.2
|
%
|
|
United Kingdom
|
|
|
0.3
|
|
0.6
|
%
|
|
|
0.6
|
|
1.0
|
%
|
|
Austria
|
|
|
0.2
|
|
0.4
|
%
|
|
|
0.3
|
|
0.5
|
%
|
|
Sweden
|
|
|
0.2
|
|
0.4
|
%
|
|
|
0.1
|
|
0.2
|
%
|
|
Denmark
|
|
|
0.1
|
|
0.2
|
%
|
|
|
0.2
|
|
0.3
|
%
|
|
Totals
|
|
$
|
50.9
|
|
100
|
%
|
|
$
|
60.7
|
|
100
|
%
|
________________________
(1) Mexico began operations in January 2011.
The number of new and continuing independent associates and members who
purchased our packs or products during the twelve months ended March 31,
2011 and 2010 were as follows:
|
|
|
|
|
|
|
|
|
2011
|
|
|
|
|
2010
|
|
|
|
New
|
|
|
|
|
|
|
|
87,000
|
|
|
|
22.3
|
%
|
|
|
|
129,000
|
|
|
|
26.6
|
%
|
|
|
Continuing
|
|
|
|
|
|
|
|
305,000
|
|
|
|
77.7
|
%
|
|
|
|
356,000
|
|
|
|
73.4
|
%
|
|
|
Total
|
|
|
|
|
|
|
|
392,000
|
|
|
|
100
|
%
|
|
|
|
485,000
|
|
|
|
100
|
%
|
|
|
|
|
|
|
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS – (UNAUDITED)
(in thousands, except per share information)
|
|
|
|
|
|
|
|
Three months ended March 31,
|
|
|
|
|
2011
|
|
|
|
2010
|
|
|
Net sales
|
|
$
|
50,900
|
|
|
$
|
60,665
|
|
|
Cost of sales
|
|
|
7,214
|
|
|
|
8,625
|
|
|
Commissions and incentives
|
|
|
21,707
|
|
|
|
26,999
|
|
|
|
|
|
28,921
|
|
|
|
35,624
|
|
|
Gross profit
|
|
|
21,979
|
|
|
|
25,041
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
Selling and administrative expenses
|
|
|
16,018
|
|
|
|
16,471
|
|
|
Depreciation and amortization
|
|
|
2,801
|
|
|
|
2,917
|
|
|
Other operating costs
|
|
|
8,066
|
|
|
|
8,545
|
|
|
Total operating expenses
|
|
|
26,885
|
|
|
|
27,933
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(4,906
|
)
|
|
|
(2,892
|
)
|
|
Interest expense
|
|
|
(20
|
)
|
|
|
(29
|
)
|
|
Other income, net
|
|
|
267
|
|
|
|
140
|
|
|
Loss before income taxes
|
|
|
(4,659
|
)
|
|
|
(2,781
|
)
|
|
|
|
|
|
|
|
(Provision) benefit for income taxes
|
|
|
(119
|
)
|
|
|
—
|
|
|
Net loss
|
|
$
|
(4,778
|
)
|
|
$
|
(2,781
|
)
|
|
|
|
|
|
|
|
Loss per share:
|
|
|
|
|
|
Basic
|
|
$
|
(0.18
|
)
|
|
$
|
(0.11
|
)
|
|
Diluted
|
|
$
|
(0.18
|
)
|
|
$
|
(0.11
|
)
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding:
|
|
|
|
|
|
Basic
|
|
|
26,490
|
|
|
|
26,482
|
|
|
Diluted
|
|
|
26,490
|
|
|
|
26,482
|
|
|
|
|
|
|
|
|
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
March 31, 2011
|
|
December 31, 2010
|
|
ASSETS
|
|
(unaudited)
|
|
|
|
Cash and cash equivalents
|
|
$
|
17,035
|
|
|
$
|
21,584
|
|
|
Restricted cash
|
|
|
1,266
|
|
|
|
1,265
|
|
|
Accounts receivable, net of allowance of $17 and $21 in 2011 and
2010, respectively
|
|
|
178
|
|
|
|
416
|
|
|
Income tax receivable
|
|
|
886
|
|
|
|
917
|
|
|
Inventories, net
|
|
|
21,840
|
|
|
|
24,070
|
|
|
Prepaid expenses and other current assets
|
|
|
4,457
|
|
|
|
4,356
|
|
|
Deferred tax assets
|
|
|
2,701
|
|
|
|
2,607
|
|
|
Total current assets
|
|
|
48,363
|
|
|
|
55,215
|
|
|
Property and equipment, net
|
|
|
16,379
|
|
|
|
18,449
|
|
|
Construction in progress
|
|
|
413
|
|
|
|
524
|
|
|
Long-term restricted cash
|
|
|
3,929
|
|
|
|
3,532
|
|
|
Other assets
|
|
|
2,909
|
|
|
|
3,054
|
|
|
Long-term deferred tax assets
|
|
|
643
|
|
|
|
649
|
|
|
Total assets
|
|
$
|
72,636
|
|
|
$
|
81,423
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
Current portion of capital leases
|
|
$
|
1,169
|
|
|
$
|
1,328
|
|
|
Accounts payable
|
|
|
5,682
|
|
|
|
5,534
|
|
|
Accrued expenses
|
|
|
10,308
|
|
|
|
10,318
|
|
|
Commissions and incentives payable
|
|
|
6,645
|
|
|
|
9,166
|
|
|
Taxes payable
|
|
|
2,392
|
|
|
|
3,721
|
|
|
Current deferred tax liability
|
|
|
211
|
|
|
|
243
|
|
|
Deferred revenue
|
|
|
1,775
|
|
|
|
1,930
|
|
|
Total current liabilities
|
|
|
28,182
|
|
|
|
32,240
|
|
|
Capital leases, excluding current portion
|
|
|
1,255
|
|
|
|
1,204
|
|
|
Long-term deferred tax liabilities
|
|
|
1,383
|
|
|
|
1,903
|
|
|
Other long-term liabilities
|
|
|
5,396
|
|
|
|
4,996
|
|
|
Total liabilities
|
|
|
36,216
|
|
|
|
40,343
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity:
|
|
|
|
|
|
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no
shares issued or outstanding
|
|
|
—
|
|
|
|
—
|
|
|
Common stock, $0.0001 par value, 99,000,000 shares authorized, 27,697,560
shares issued and 26,490,466 shares outstanding as of March 31,
2011 and 27,697,560 shares issued and 26,490,466 shares
outstanding as of December 31, 2010
|
|
|
3
|
|
|
|
3
|
|
|
Additional paid-in capital
|
|
|
42,146
|
|
|
|
42,049
|
|
|
Retained earnings
|
|
|
10,349
|
|
|
|
15,127
|
|
|
Accumulated other comprehensive loss
|
|
|
(1,287
|
)
|
|
|
(1,308
|
)
|
|
Less treasury stock, at cost, 1,207,094 shares in 2011 and 2010
|
|
|
(14,791
|
)
|
|
|
(14,791
|
)
|
|
Total shareholders’ equity
|
|
|
36,420
|
|
|
|
41,080
|
|
|
Total liabilities and shareholders’ equity
|
|
$
|
72,636
|
|
|
$
|
81,423
|
|
